News - Catena

Filter

Current filters:

Catena

Popular Filters

Santhera gets exclusive rights from NIH for novel approach to pp multiple sclerosis treatment

06-06-2013

Swiss Santhera Pharmaceuticals (SIX: SANN) says that it has obtained an exclusive license from the USA's…

CatenaLicensingNeurologicalPatentsPharmaceuticalSanthera Pharmaceuticals

IDSMB backs continuation of Santhera's Ph III Catena trial in DMD, but now needs partner

16-04-2013

Swiss drugmaker Santhera Pharmaceuticals (SIX: SANN) says that the Phase III DELOS study of orally administered…

CatenaLicensingPharmaceuticalRare diseasesResearchSanthera Pharmaceuticals

Back to top